Allogene Therapeutics, Inc. (NASDAQ:ALLO) Cap table

Allogene Therapeutics, Inc.

Cap table

Built by 6ix from Allogene Therapeutics, Inc.’s releases · as of Nov 3, 2026

Common shares
346,467,307
Fully diluted
346,467,307

Fully diluted

LineSharesAs of
Common shares346,467,307Nov 3, 2026

Share count over time

CountShares
Nov 3, 2026346,467,307